gastrointestinal

| Article

The U.S. Food and Drug Administration today permitted marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome (IBS) when combined with other therapies for IBS. IBS is a condition affecting the large...

| Article

Testing for celiac (or “coeliac” in Australia) disease and gut damage in pediatric patients can be a painful and invasive process involving endoscopic procedures, but that necessity may someday be replaced by a new and simpler diagnostic tool that analyses the patient’s breath for evidence of...

Subscribe to gastrointestinal

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.